Literature DB >> 19367581

Identification of neuroglycan C and interacting partners as potential susceptibility genes for schizophrenia in a Southern Chinese population.

Hon-Cheong So1, Pui Y Fong, Ronald Y L Chen, Tomy C K Hui, Mandy Y M Ng, Stacey S Cherny, William W M Mak, Eric F C Cheung, Raymond C K Chan, Eric Y H Chen, Tao Li, Pak C Sham.   

Abstract

Chromosome 3p was reported by previous studies as one of the regions showing strong evidence of linkage with schizophrenia. We performed a fine-mapping association study of a 6-Mb high-LD and gene-rich region on 3p in a Southern Chinese sample of 489 schizophrenia patients and 519 controls to search for susceptibility genes. In the initial screen, 4 SNPs out of the 144 tag SNPs genotyped were nominally significant (P < 0.05). One of the most significant SNPs (rs3732530, P = 0.0048) was a non-synonymous SNP in the neuroglycan C (NGC, also known as CSPG5) gene, which belongs to the neuregulin family. The gene prioritization program Endeavor ranked NGC 8th out of the 129 genes in the 6-Mb region and the highest among the genes within the same LD block. Further genotyping of NGC revealed 3 more SNPs to be nominally associated with schizophrenia. Three other genes (NRG1, ErbB3, ErbB4) involved in the neuregulin pathways were subsequently genotyped. Interaction analysis by multifactor dimensionality reduction (MDR) revealed a significant two-SNP interaction between NGC and NRG1 (P = 0.015) and three-SNP interactions between NRG1 and ErbB4 (P = 0.009). The gene NGC is exclusively expressed in the brain. It is implicated in neurodevelopment in rats and was previously shown to promote neurite outgrowth. Methamphetamine, a drug that may induce psychotic symptoms, was reported to alter the expression of NGC. Taken together, these results suggest that NGC may be a novel candidate gene, and neuregulin signaling pathways may play an important role in schizophrenia. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19367581     DOI: 10.1002/ajmg.b.30961

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  14 in total

Review 1.  Pathogenesis of Börjeson-Forssman-Lehmann syndrome: Insights from PHF6 function.

Authors:  Arezu Jahani-Asl; Cheng Cheng; Chi Zhang; Azad Bonni
Journal:  Neurobiol Dis       Date:  2016-09-12       Impact factor: 5.996

Review 2.  Extracellular matrix proteomics in schizophrenia and Alzheimer's disease.

Authors:  Manveen K Sethi; Joseph Zaia
Journal:  Anal Bioanal Chem       Date:  2016-09-06       Impact factor: 4.142

3.  The X-linked intellectual disability protein PHF6 associates with the PAF1 complex and regulates neuronal migration in the mammalian brain.

Authors:  Chi Zhang; Luis A Mejia; Ju Huang; Pamela Valnegri; Eric J Bennett; Julius Anckar; Arezu Jahani-Asl; Gilbert Gallardo; Yoshiho Ikeuchi; Tomoko Yamada; Michael Rudnicki; J Wade Harper; Azad Bonni
Journal:  Neuron       Date:  2013-06-19       Impact factor: 17.173

4.  A novel relationship for schizophrenia, bipolar and major depressive disorder Part 5: a hint from chromosome 5 high density association screen.

Authors:  Xing Chen; Feng Long; Bin Cai; Xiaohong Chen; Gang Chen
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

5.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

Review 6.  Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases.

Authors:  Lin Mei; Klaus-Armin Nave
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

Review 7.  Personalized medicine in psychiatry: problems and promises.

Authors:  Uzoezi Ozomaro; Claes Wahlestedt; Charles B Nemeroff
Journal:  BMC Med       Date:  2013-05-16       Impact factor: 8.775

8.  Aggrecan and chondroitin-6-sulfate abnormalities in schizophrenia and bipolar disorder: a postmortem study on the amygdala.

Authors:  H Pantazopoulos; M Markota; F Jaquet; D Ghosh; A Wallin; A Santos; B Caterson; S Berretta
Journal:  Transl Psychiatry       Date:  2015-01-20       Impact factor: 6.222

Review 9.  Proteoglycans and neuronal migration in the cerebral cortex during development and disease.

Authors:  Nobuaki Maeda
Journal:  Front Neurosci       Date:  2015-03-23       Impact factor: 4.677

10.  Association between ErbB4 single nucleotide polymorphisms and susceptibility to schizophrenia: A meta-analysis of case-control studies.

Authors:  Yanguo Feng; Dejun Cheng; Chaofeng Zhang; Yuchun Li; Zhiying Zhang; Juan Wang; Xiao Feng
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.